Tuberculosis and Respiratory Diseases

Search

Page Path

HOME
Search

Original Articles

Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014: Scott K. Heysell, Jane L. Moore, Charles A. Peloquin, David Ashkin, Eric R. Houpt; Tuberc Respir Dis. 2015;78(2):78-84. Published online April 2, 2015; DOI: https://doi.org/10.4046/trd.2015.78.2.78
Web of Science 27 Crossref 25; Full text PubReader PDF

Pharmacokinetics of ofloxacin in Patients with Multidrug-Resistant Tuberculosis.: Seung Kyu Park, Young Ran Yoon, Woo Chul Lee, Hyung Min Jun, Ji Hong Shon, Kyoung Ah Kim, Ji Young Park, Jae Gook Shin; Tuberc Respir Dis. 2002;52(2):128-136. Published online February 1, 2002; DOI: https://doi.org/10.4046/trd.2002.52.2.128
Crossref 1; PDF

Pharmacokinetic Profiles of Isoniazid and Rifampicin in Korean Tuberculosis Patients.: Seok Jin Ahn, Sang Joon Park, Kyeong Woo Kang, Gee Young Suh, Man Pyo Chung, Hojoong Kim, Jung Kwon, Chong H Rhee, Hee Soo Cha, Myoung Min Kim, Kyung Eob Choi; Tuberc Respir Dis. 1999;47(4):442-450. Published online October 1, 1999; DOI: https://doi.org/10.4046/trd.1999.47.4.442
Crossref 2; PDF

Pharmacokinetic Study of Isoniazid and Rifampicin in Healthy Korean Volunteers.: Man Pyo Chung, Ho Cheol Kim, Gee Young Suh, Jeong Woong Park, Ho Joong Kim, O Jung Kwon, Chong H Rhee, Yong Choi Han, Hyo Jung Park, Myoung Min Kim, Kyung Eob Choi; Tuberc Respir Dis. 1997;44(3):479-492. Published online June 1, 1997; DOI: https://doi.org/10.4046/trd.1997.44.3.479
Crossref 2; PDF

Volume 87, No. 2

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

Impact Factor

2.9

MOST VIEWED MOST CITED

9,532	The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
4,353	Subphenotypes of Acute Respiratory Distress Syndrome: Advancing Towards Precision Medicine
2,527	Early Mobilization and Rehabilitation of Critically-Ill Patients
2,299	Association between Antacid Exposure and Risk of Interstitial Lung Diseases
14,123	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria

Cited By 25	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
Cited By 14	Tuberculosis: Republic of Korea, 2021
Cited By 12	Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
Cited By 10	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
Cited By 10	Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae

ARTICLE & TOPICS

Article category

Browse all articles >

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

prev

next